(secondQuint)BioWick SureLock Clinical Outcomes Study.

 Study Title Efficacy of the BioWick cent SureLock cent Implant for the Reattachment of Soft Tissue to Bone in Subjects Undergoing Rotator Cuff Repairs Sponsor Cayenne Medical, Inc.

, a Zimmer Biomet company Study Design The study is a prospective, non-randomized, open-label, single-arm study that includes both preoperative assessments and follow-up assessments at 3 months, 6 months, 12 months, and 24 months.

 Clinical Phase Postmarket Number of Sites Up to ten sites in the U.

S.

 Study Duration per Subject Subjects will be enrolled in the study for up to 24 months.

 Primary Objective The primary objective of this study is to assess the structural failure rate with the use of the BioWick cent SureLock cent implant.

 Secondary Objective The secondary objectives of this study are : - To document the postmarket effectiveness of the BioWick cent SureLock cent implant using range of motion measurements, ASES scores, VR-12 scores, and VAS scores, with the corresponding assessments made at 3 months, 6 months, 12 months, and 24 months.

 - To document device safety via device-related adverse events reported over the course of the study.

.

 BioWick SureLock Clinical Outcomes Study@highlight

The purpose of this study is to collect postmarket data in subjects who receive surgical treatment of a full-thickness rotator cuff tear (of at least 1.

5 cm) with the BioWick cent SureLock cent implant.

 Both performance and safety data will be collected.

